Barringtogenol C(13844-01-4)
- Name: Barringtogenol C
- Synonyms:Giganteumgenin M;Jegosapogenol A;Escinidin;Careyagenol A;(3R,4R,4aR,5R,6aS,6bR,12aR)-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-3,4,5,10-tetraol;Aescinidin;Theasapogenol B;Barringtogenol C;Saniculagenin D;(3R,4R,4aR,5R,6aR,6aS,6bR,8aR,10S,12aR,14bS)-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-3,4,5,10-tetrol;Jegosapogenol;
- Molecular Formula:C30H50O5
- Molecular Weight:490.724
- CAS Registry Number:13844-01-4
- EINECS:
- Melting Point:315-320 °C (decomp)
- Water Solubility:
CAS No.13844-01-4 Barringtogenol C
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
Other Product
- 30080-29-6/(R)-4,6-Dihydroxy-4-[(R)-1-hydroxyethyl]-5-oxohexanal
- 102504-34-7/2-(4-chlorophenyl)-5-(3-pyrrolidin-1-ylpropyl)-2,3-dihydro-1,3,4-oxadi azole chloride
- 5273-35-8/4,5-bis[(4-chlorobenzyl)sulfanyl]-2-phenyl-3(2H)-pyridazinone
- 82464-33-3/methyl 19-(2-hydroxyethyl)ibogamine-18-carboxylate
- 65202-62-2/methyl 3,4,5,7-tetrahydro-3-oxoisoxazolo[5,4-c]pyridine-6(2H)-carboxylate
- 28875-92-5/MK 485
- 57377-32-9/HYMENOXON
- 79763-37-4/3-{3-[(butoxycarbonyl)amino]phenoxy}-2-hydroxy-N-(propan-2-yl)propan-1-aminium chloride
- 51602-26-7/Limbatril F
- 21709-91-1/2H,6H-Benzo[1,2-b:5,4-b']dipyran-2-one,10-(1,1-dimethylpropyl)-7,8-dihydro-5-methoxy-8,8-dimethyl- (9CI)
- 53-85-0/5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole
- 95968-43-7/5,11-Dihydro-5-((4-methyl-1-piperazinyl)acetyl)amino(1)benzoxepino(3,4-b)pyridine fumarate H2O
- 111052-61-0/3-butyl-7-hydroxy-4-methyl-6-propyl-2H-chromen-2-one
- 155233-15-1/6-deoxy-1-O-{[6-(3-methylbut-2-en-1-yl)phenazin-1-yl]carbonyl}-alpha-L-talopyranose
- 107679-90-3/1-{[(4S,5R)-4-(4-chlorophenyl)-5-(2,4-dichlorophenyl)-2-pentyl-1,3-dioxolan-4-yl]methyl}-1H-1,2,4-triazole
- 5972-45-2/(9Z)-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]octadec-9-enamide
- 4395-64-6/6,7-Phthaloylindazole
- 5387-97-3/4-(benzylsulfanyl)-6,7-dimethoxycinnoline
- 160237-25-2/7-O-(Methylsulfanylmethyl)paclitaxel
- 13844-01-4/Barringtogenol C
- 53496-32-5/9-(2,3-di-O-benzyl-5-S-methyl-5-thiopentofuranosyl)-9H-purin-6-amine
- 17010-59-2/4-[(4-Chloro-3-methylphenyl)azo]-N,N-dimethylbenzenamine
- 83162-90-7/2-[6-(1-carboxyethyl)naphthalen-2-yl]propanoic acid
- 102432-93-9/8-Azoniabicyclo[3.2.1]octane,3-[(cyclohexylphenylacetyl)oxy]-8-[(4-ethylphenyl)methyl]-8-methyl-, bromide,endo- (9CI)
- 68391-48-0/3,3'-[(phenylimino)bis(ethane-2,1-diyloxy)]bispropiononitrile
- 50885-98-8/1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with 1,3-diisocyanatomethylbenzene and methyloxirane
- 3230-76-0/3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,7-triene-1,6-diol
- 148175-00-2/Phosphinoselenoichydrazide (9CI)
- 109672-71-1/2-FPE
- 2779-59-1/2-[2-(1-oxido-1,4-thiazepan-4-yl)ethyl]guanidine sulfate (1:1)